Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jan 1;40(1):69-70.
doi: 10.1093/eurheartj/ehy779.

Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension

Affiliations
Comment

Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension

Satish R Raj et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • 2018 ESC Guidelines for the diagnosis and management of syncope.
    Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group. Brignole M, et al. Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037. Eur Heart J. 2018. PMID: 29562304 No abstract available.

References

    1. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H.. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 2017;264:1567–1582. - PMC - PubMed
    1. Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG, Torbicki A, Moreno J, Aboyans V, Agewall S, Asteggiano R, Blanc J-J, Bornstein N, Boveda S, Bueno H, Burri H, Coca A, Collet J-P, Costantino G, Díaz-Infante E, Delgado V, Dolmans F, Gaemperli O, Gajek J, Hindricks G, Kautzner J, Knuuti J, Kulakowski P, Lambrinou E, Leclercq C, Mabo P, Morillo CA, Piepoli MF, Roffi M, Shen WK, Simpson IA, Stockburger M, Vanbrabant P, Windecker S, Zamorano JL, Barbato E, Coman IM, Dean V, Fitzsimons D, Iung B, Jüni P, Katus HA, Lancellotti P, McDonagh T, Ponikowski P, Richter DJ, Shlyakhto E, Sousa-Uva M, Roithinger FX, Chasnoits A, Vandekerckhove Y, Traykov VB, Puljevic D, Papasavvas E, Mølgaard H, Nawar M, Parikka H, Vavlukis M, Piot O, Etsadashvili K, Klingenheben T, Deftereos S, Sághy L, Gudmundsson K, Beinart R, Raviele A, Abdrakhmanov A, Mirrakhimov E, Kalejs O, Benlamin HA, Puodziukynas A, Dimmer C, Sammut MA, Raducan A, Vukmirović M, Abdelali S, Hemels MEW, Haugaa KH, Baranowski R, Cunha PS, Dan G-A, Tyurina T, Bertelli L, Mitro P, Lozano IF, Bergfeldt L, Osswald S, Afef BH, Özdemír HM, Lim PB; ESC Scientific Document Group. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J 2018;39:1883–1948. - PubMed
    1. Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ.. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis 2016;6:751–759. - PubMed
    1. Kymes S, François C, McLeod K, Duhig A, Ogbonnaya A, Quillen A, Cannon J, Shibao CA, Yue B, Biaggioni I. Patient-reported outcomes in a prospective real-world study of droxidopa for the treatment of neurogenic orthostatic hypotension. Mov Disord 2017;32:281.

Publication types